ARIA Commodities Announces US$135 Million Reverse Takeover of London listed Kibo Energy, by Carbon Resilience, a 14GW Australian Renewable Energy Platform
9.10.2025 18:01:00 CEST | Business Wire | Press release
The institutional asset management platform of ARIA Commodities’ group today announced a reverse takeover (RTO) transaction with Kibo Energy PLC (AIM: KIBO; AltX: KBO), the dual-listed energy development company.
The US$135 million acquisition, transacted in concert with ARIA’s group institutional asset management business, will be satisfied through the issuance of approximately 966 million new Kibo shares at a deemed price of £0.104 per share, following a proposed 1,600-to-1 share consolidation. The transaction marks a significant reverse takeover (RTO) under AIM Rule 14 and represents Kibo’s strategic pivot toward large-scale, global industrial decarbonisation.
A Portfolio with Global Potential
Carbon Resilience controls a portfolio of eight strategically located renewable energy sites across Queensland, spanning more than 900,000 hectares and offering a potential generation capacity exceeding 14 gigawatts (GW).
The projects combine onshore wind, solar PV and battery energy storage systems (BESS) to deliver firm, dispatchable clean-power solutions supporting:
- National grid supply,
- Industrial electrification,
- Data-centre power resilience,
- Critical minerals processing,
- Green steel and low-carbon fuels production.
Unparalleled Green Electron Transition Opportunity
Matt Brittain, CIO at ARIA Commodities, commented:
“We’ve instituted a process which paves the way for realising significant value in what constitutes one of APAC’s largest green electron opportunities. Supported by a world class global and local development team, the transaction will afford the opportunity for institutions, industry participants and commercial end users, to participate in an almost peerless Power-2-X proposition.”
The proposed RTO is expected to re-admit Kibo to trading on AIM following shareholder approval and regulatory sign-off. Once completed, the enlarged group will partner with global blue chip partners to deliver a decarbonisation platform which includes sustainable aviation fuel, green steel and marine fuels.
More information:
https://www.londonstockexchange.com/stock/KIBO/kibo-energy-plc/company-page
https://www.treasury.qld.gov.au/
https://www.linkedin.com/company/aria-commodities/
About ARIA Commodities
ARIA Commodities brings a unique blend of origination, operational and marketing capabilities to a commodity trading, asset and infrastructure platform, with its centre of gravity in energy related infrastructure. From biofuels to circular economies and decarbonised production and trading activities, ARIA Commodities seeks to make a meaningful contribution to an energy competitive world. Headquartered in Dubai, ARIA has offices in 12 countries and operates assets over multiple continents.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20251009166491/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brightfin Unveils AI-Native Platform for IT Financial Management30.4.2026 17:00:00 CEST | Press release
Brightfin clients drive their businesses forward with the first AI Native Cost Optimization Platform Brightfin, the only ITFM and Technology Expense Management solution built natively on ServiceNow, today announced an AI-Native architecture that fundamentally improves how organizations manage IT spend. Rather than bolting AI onto legacy systems, Brightfin has engineered intelligence from the ground up - starting with the data, building contextual awareness on top of it, and delivering AI agents that speak the language of IT finance. Brightfin’s unified budget-to-billing data model creates a stable, governed foundation that connects contracts, invoices, inventory, and budgets into a single source of truth - something no external ITFM tool or native platform module can replicate. This is a structured financial backbone purpose-built for enterprise IT spend, and it’s what makes everything above it possible. A context-aware, AI-Native, intelligence layer understands relationships across th
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 15:22:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et
Experian Announces Agent Trust to Power Trusted AI Driven Commerce30.4.2026 15:00:00 CEST | Press release
First-of-its-kind human-to-agent binding service for secure AI-driven commerce, developed with a growing ecosystem of agentic commerce collaborators, including Visa, Cloudflare and Skyfire Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430719198/en/ Experian Announces Agent Trust to Power Trusted AI Driven Commerce. As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions. Experian Agent Trust addresses this challenge through a new “Kn
Meet the AI-powered fan companion: TGR Haas F1 Team RaceMate powered by Infobip30.4.2026 15:00:00 CEST | Press release
New always-on conversational agent with team race intelligence, team insights, and interactive experiences powered by Infobip AgentOS Global AI-first cloud communications platform Infobip and TGR Haas F1 team are launching ‘TGR Haas F1 Team RaceMate powered by Infobip’, an AI-powered conversational fan companion on Apple Messages for Business and WhatsApp Business Platform. Always-on and always available, it delivers race intelligence for TGR Haas F1 Team: team race intelligence, grid positions, qualifying outcomes, sprint results, and full session schedules. The AI agent tracks drivers Ollie Bearman and Esteban Ocon with their individual championship standings and performance data in conversational format. The agent draws from a knowledge base covering driver biographies, team history, and circuit data, adapting to each user's knowledge level. Every interaction begins with a schedule check, ensuring fans always know what's happening right now. It proactively surfaces relevant informat
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 14:05:00 CEST | Press release
Significant unmet need remains for 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burdenEnpatoran, an oral TLR7/8 inhibitor, is designed for lupus patients with active cutaneous manifestations, with the goal of broadening the treatment paradigm beyond the current standardsELOWEN is a global Phase 3 program evaluating enpatoran’s impact on both skin and systemic symptoms in patients with lupus and potential links between skin and systemic disease activity Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom